Silence Therapeutics plc reported earnings of -$ 0.24 per SLN share on Nov 12, 2026, beating analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.11 |
| Earnings Per Share (Surprise) | -$ 0.24 (-$ 0.13) |
| Last Year's EPS | -$ 0.46 |
| EPS YoY Change |
Out of the last 54 earnings reporting periods, Silence Therapeutics plc beat analysts’ expectations 12 times and fell short of expectations 9 time(s). Silence Therapeutics plc reported earnings per share of -$ 0.24 in the last report falling to reach an estimated EPS of -$ 0.11 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.11 | -$ 0.24 | -$ 0.45 | |
| Aug 10, 2026 | -$ 0.13 | -$ 0.26 | -$ 0.54 | |
| May 7, 2026 | -$ 0.33 | -$ 0.32 | -$ 0.60 | |
| Mar 5, 2026 | -$ 0.32 | -$ 0.25 | $ 0.27 | |
| Nov 6, 2025 | -$ 0.40 | -$ 0.45 | -$ 0.75 | |
| Aug 7, 2025 | -$ 0.27 | -$ 0.54 | -$ 0.42 | |
| May 8, 2025 | -$ 0.18 | -$ 0.60 | -$ 0.05 | |
| Feb 27, 2025 | -$ 0.45 | $ 0.27 | -$ 0.47 | |
| Nov 14, 2024 | -$ 0.42 | -$ 0.75 | -$ 0.28 | |
| Aug 15, 2024 | -$ 0.32 | -$ 0.42 | -$ 0.36 | |
| May 16, 2024 | -$ 0.23 | -$ 0.05 | -$ 0.35 | |
| Mar 13, 2024 | -$ 0.25 | -$ 0.47 | -$ 0.46 | |
| Nov 14, 2023 | -$ 0.56 | -$ 0.28 | -$ 0.25 | |
| Aug 16, 2023 | -$ 0.59 | -$ 0.36 | -$ 0.16 | |
| May 16, 2023 | -$ 0.51 | -$ 0.35 | -$ 0.11 | |
| Mar 15, 2023 | $ 0.45 | -$ 0.46 | -$ 0.42 | |
| Nov 10, 2022 | -$ 0.60 | -$ 0.25 | -$ 0.29 | |
| Aug 11, 2022 | -$ 0.19 | -$ 0.16 | -$ 0.45 | |
| May 16, 2022 | -$ 0.19 | -$ 0.11 | -$ 0.33 | |
| Mar 17, 2022 | -$ 0.62 | -$ 0.42 | -$ 0.21 |
Silence Therapeutics plc’s stock was trading at $ 19.77 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, SLN’s price increased to $ 19.83 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.24 | $ 19.77 | $ 19.83 | |
| Aug 10, 2026 | -$ 0.26 | $ 11.95 | $ 14.72 | |
| May 7, 2026 | -$ 0.32 | $ 7.36 | $ 6.97 | |
| Mar 5, 2026 | -$ 0.25 | $ 5.78 | $ 6.23 | |
| Nov 6, 2025 | -$ 0.45 | $ 6.24 | $ 6.58 | |
| Aug 7, 2025 | -$ 0.54 | $ 5.32 | $ 5.04 | |
| May 8, 2025 | -$ 0.60 | $ 3.70 | $ 3.70 | |
| Feb 27, 2025 | $ 0.27 | $ 4.77 | $ 4.50 | |
| Nov 14, 2024 | -$ 0.75 | $ 15.24 | $ 12.70 | |
| Aug 15, 2024 | -$ 0.42 | $ 16.26 | $ 15.69 | |
| May 16, 2024 | -$ 0.05 | $ 22.33 | $ 23.00 | |
| Mar 13, 2024 | -$ 0.47 | $ 25.90 | $ 23.83 | |
| Nov 14, 2023 | -$ 0.28 | $ 9.01 | $ 9.42 | |
| Aug 16, 2023 | -$ 0.36 | $ 6.12 | $ 6.81 | |
| May 16, 2023 | -$ 0.35 | $ 5.87 | $ 5.45 | |
| Mar 15, 2023 | -$ 0.46 | $ 9.66 | $ 8.99 | |
| Nov 10, 2022 | -$ 0.25 | $ 11.75 | $ 13.01 | |
| Aug 11, 2022 | -$ 0.16 | $ 10.04 | $ 9.81 | |
| May 16, 2022 | -$ 0.11 | $ 9.90 | $ 9.73 | |
| Mar 17, 2022 | -$ 0.42 | $ 17.00 | $ 16.87 |
Silence Therapeutics plc released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Silence Therapeutics plc missed analysts’ expectations during the last earnings period by
